in this issue
People & Business :: Companies
Bayer's life sciences units lift results, MaterialScience hampered by costs; 2013 outlook confirmed
8:20 AM MDT | April 25, 2013 | Natasha Alperowicz
Bayer reported a “positive development” in its life sciences operations, comprising HealthCare and CropScience, in the first quarter but said that MaterialScience’s results were hampered by raw material costs. The company has, meanwhile, confirmed its outlook for the rest of 2013. Bayer’s chairman Marijn Dekkers, announcing the results today, said that the company continues to see attractive perspectives for 2013, Bayer’s 150th anniversary year. “We confirm our outlook for the Bayer Group,” he said...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee